The SIAMS-ED Trial: A National, Independent, Multicentre Study on Cardiometabolic and Hormonal Impairment of Men with Erectile Dysfunction Treated with Vardenafil

Table 2

Partial correlations adjusted for age and smoking.

Variable	IIEF5 score	IIEF5; 4 categories	IIEF5; 2 categories	CV risk categories	Pulse pressure	MS yes versus no	MS number of criteria	Testosterone
IIEF-5 4 categories	−0.949*; 𝑃=0.000
IIEF-5 2 categories	−0.815*; 𝑃=0.000	0.874*; 𝑃=0.000
CVR categories	−0.113^§; 𝑃=0.045	0.156^‡; 𝑃=0.005	0.142^§; 𝑃=0.043
Pulse pressure	−0.124^§; 𝑃=0.013	0.112^§; 𝑃=0.017	0.111^§; 𝑃=0.018	0.148^‡; 𝑃=0.006
MS yes versus no	0.093; 𝑃=0.305	−0.052; 𝑃=0.535	−0.056; 𝑃=0.504	0.006; 𝑃=0.952	0.081; 𝑃=0.315
MS number of criteria	0.039; 𝑃=0.624	−0.026; 𝑃=0.726	−0.05; 𝑃=0.497	0.093; 𝑃=0.267	0.052; 𝑃=0.463	0.844*; 𝑃=0.000
Testosterone	−0.031; 𝑃=0.726	−0.078; 𝑃=0.274	−0.017; 𝑃=0.811	−0.149^§; 𝑃=0.046	−0.057; 𝑃=0.453	−0.072; 𝑃=0.566	−0.123; 𝑃=0.253
Waist circumference	−0.003; 𝑃=0.962	0.021; 𝑃=0.743	−0.048; 𝑃=0.453	0.175^§; 𝑃=0.012	0.146^§; 𝑃=0.018	0.302^‡; 𝑃=0.003	0.245^‡; 𝑃=0.008	−0.197^§; 𝑃=0.035

IIEF-5 categories: mild ED versus mild to moderate ED versus moderate ED versus severe ED.
IIEF-5 2 categories: mild and mild to moderate ED versus moderate and severe ED.
^∗𝑃<0.0001, ^†𝑃<0.001, ^‡𝑃<0.01, and ^§𝑃<0.05.